Article Versions Notes

Capitao M, Perrin J, Simon S, Gouard S, Chouin N, Bruchertseifer F, Morgenstern A, Rbah-Vidal L, Chérel M, Scotet E, et al. Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model. Cancers. 2021; 13(6):1256. https://doi.org/10.3390/cancers13061256

Capitao, Marisa, Justine Perrin, Sylvain Simon, Sébastien Gouard, Nicolas Chouin, Frank Bruchertseifer, Alfred Morgenstern, Latifa Rbah-Vidal, Michel Chérel, Emmanuel Scotet, and et al. 2021. "Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model" Cancers 13, no. 6: 1256. https://doi.org/10.3390/cancers13061256

Capitao, M., Perrin, J., Simon, S., Gouard, S., Chouin, N., Bruchertseifer, F., Morgenstern, A., Rbah-Vidal, L., Chérel, M., Scotet, E., Labarrière, N., Guilloux, Y., & Gaschet, J. (2021). Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model. Cancers, 13(6), 1256. https://doi.org/10.3390/cancers13061256